Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Share News

LONDON MARKET MIDDAY: FTSE 100 stays green as Bunzl bumps guidance

27th Aug 2024 11:48

(Alliance News) - Stock prices in London were predominantly higher on Tuesday, as the FTSE 100 enjoyed a boost from bumper Bunzl guidance, and a strong start from resource firms. Read More

AIM WINNERS & LOSERS: Belluscura shares up on expected revenue boost

27th Aug 2024 10:46

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

Allergy Therapeutics secures cash to see it through September

27th Aug 2024 09:57

(Alliance News) - Allergy Therapeutics PLC shares fell on Tuesday, despite securing an additional GBP5 million in loans, extending its cash runway. Read More

TRADING UPDATES: Croma Security trading well; Fonix to up final payout

22nd Jul 2024 16:26

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: Arecor Therapeutics dives on funding needs

10th Jun 2024 10:32

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

Allergy Therapeutics welcomes peanut allergy vaccine trial results

10th Jun 2024 09:36

(Alliance News) - Allergy Therapeutics PLC on Monday hailed positive findings from trial results for a peanut allergy vaccine. Read More

TRADING UPDATES: Abingdon Health buys IVDeology Holdings

7th May 2024 20:22

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line

27th Mar 2024 16:13

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: Norman Broadbent profit swing on rising revenue

27th Mar 2024 11:02

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

Allergy Therapeutics starts dosing patients in peanut allergy trial

12th Mar 2024 14:06

(Alliance News) - Allergy Therapeutics PLC on Tuesday said it has commenced subcutaneous dosing of peanut allergic patients in its phase 1/2a Protect trial. Read More

UK shareholder meetings calendar - next 7 days

1st Mar 2024 15:49

Read More

Allergy Therapeutics forecasts revenue drop but trials going well

14th Feb 2024 10:22

(Alliance News) - Allergy Therapeutics PLC on Wednesday said revenue decreased in its latest half year, and expects to require further funding soon. Read More

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

5th Feb 2024 14:09

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Allergy Therapeutics resumes trading on AIM; annual revenue plunges

30th Jan 2024 10:38

(Alliance News) - Allergy Therapeutics PLC on Tuesday resumed trading on AIM after the release of its annual results. Read More

IN BRIEF: Allergy Therapeutics amends facility, plans warrant issue

27th Dec 2023 14:17

Allergy Therapeutics PLC - Sussex-based biotechnology company specialising in allergy vaccines - Shares rise as firm enters amendment to the facility agreement it reached in early April with SkyGem Acquisition Ltd and Southern Fox Investments Ltd. Deal provides Allergy Therapeutics with a GBP40 million secured loan facility of which GBP32.5 million is uncommitted. Facility is available to drawdown between January 15 and the same day in 2026, with interest payable semi-annually at 12% per year and a January 15, 2027 repayment date. Read More

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

15th Dec 2023 21:09

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Allergy Therapeutics shares jump as hails grass allergy jab data

13th Dec 2023 10:11

(Alliance News) - Allergy Therapeutics PLC on Wednesday said that phase-3 trials of its grass allergy injection yielded positive results, moving the product closer to market entry. Read More

AIM WINNERS & LOSERS: Impellam climbs on GBP483 million takeover offer

13th Dec 2023 09:55

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

11th Dec 2023 07:41

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite. Read More

Allergy Therapeutics says allergy therapy trial meets primary endpoint

14th Nov 2023 11:56

(Alliance News) - Allergy Therapeutics PLC on Tuesday said that a trial evaluating the efficacy of its subcutaneous allergen-specific immunotherapy candidate has met its primary endpoint. Read More

FTSE 100 Latest
Value9,918.33
Change-145.17